Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FALCI: Ferroquine and Artefenomel in Uncomplicated Malaria
NCT02497612Phase 2Terminated
- Sponsor
- Sanofi
- Start
- Jul 2015
- Primary completion
- Sep 2019
- Modality
- DNA Intercalators/Alkylators
- Countries
- 7
01
Overview
A Phase 2 trial of ferroquine, artefenomel in Plasmodium falciparum malaria, sponsored by Sanofi. Started Jul 2015; status: terminated.
02
Drugs
ferroquineartefenomel
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT02497612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02497612.